C5 and cholangiocarcinoma: Nitta et al. suggest a C5a release from C5 by a cancer cell membrane-bound serine protease and thus an autocrine activation of C5aR-expressing cancer cells (bile duct, colon and cholangiocarcinoma cell lines).